Skip to content

Prisma Capital Partners LP: MMYT position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Prisma Capital Partners LP on MMYT, newest first. How the timeline and the estimate are built.

Prisma Capital Partners LP held 0 MMYT shares at 2018-12-31 per its 13F-HR filed 2019-02-14.

the latest 13F is the newest step

  1. period ended2018-12-31
    13F 0 shares
    Change vs previous 13F -234,715 shares

    13F-HR 0001172661-19-000783 filed by Prisma Capital Partners LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  2. period ended2018-09-30
    13F 234,715 shares
    Change vs previous 13F 0 shares

    11% of the 13F portfolio, value $6,443,000.

    13F-HR 0001172661-18-002030 filed by Prisma Capital Partners LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2018-06-30
    13F/A 234,715 shares
    Change vs previous 13F 0 shares

    7.69% of the 13F portfolio, value $8,485,000.

    13F-HR/A 0001172661-18-001898 filed by Prisma Capital Partners LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2018-03-31
    13F/A 234,715 shares
    Change vs previous 13F +61,405 shares

    5.88% of the 13F portfolio, value $8,145,000.

    13F-HR/A 0001172661-18-001897 filed by Prisma Capital Partners LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2017-12-31
    13F 173,310 shares
    Change vs previous 13F not available

    4.88% of the 13F portfolio, value $5,173,000.

    13F-HR 0001172661-18-000533 filed by Prisma Capital Partners LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).